Universit Pierre Et Marie Curie competitive analysis

Explore Universit Pierre Et Marie Curie's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 2, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 2, 2022Agents For Use In The Treatment Of Retinal Inflammation1
Jan 20, 2021Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases1
May 8, 2019Phytoecdysones For Use In Improving The Muscle Quality Of Obese And/Or Sarcopenic Mammals1

Latest PTAB cases involving Universit Pierre Et Marie Curie

Discover the latest PTAB cases involving Universit Pierre Et Marie Curie, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Universit Pierre Et Marie Curie with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSIT PIERRE ET MARIE CURIE - 2 - -
SCHLICH33 - - -
VIDON BREVETS & STRATEGIE2 - - -